en · de · es · fr · pt
aod-9604-notes.peptides6908.com › Info › Identity And Research Background — Complete Guide

Identity And Research Background — Complete Guide

By Editorial Desk · published 2025-10-21 · last reviewed 2025-11-22 · Info

synthetic peptide comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.

Last reviewed on 2025-11-22. Where a claim depends on a specific study, the study is described rather than over-claimed.

Identity And Research Background

AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.

AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.

Identity and Research Origin

AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.

Development of AOD-9604 began in the 1990s as scientists sought to isolate metabolic effects of growth hormone without its growth-promoting actions. Early laboratory work focused on fat cells and animal models. Several human trials followed, examining changes in body composition and fat mass. Results have been mixed, and the peptide has not progressed to widespread clinical approval. Interest continues in research settings, particularly regarding its mechanism and potential metabolic targets.

Regulatory status varies by country. In the United States, AOD-9604 is not approved as a prescription drug. It is sometimes sold as a research chemical or dietary supplement, though such marketing may fall outside legal frameworks. The World Anti-Doping Agency prohibits its use in sport. Researchers must obtain it through legitimate suppliers and follow institutional rules. Its legal classification continues to evolve as authorities increasingly assess peptide products more broadly.

Aod-9604 at a glance

PropertyValueNotes
Molecular classSynthetic peptideFragment analog of human growth hormone
Sequence basishGH 176–191 regionModified C-terminal fragment
Common synonymsAOD-9604; AOD9604; hGH fragmentResearch and trade names vary
Regulatory statusNot approved as a drugProhibited in competitive sport
Research codeAOD9604Used in scientific and patent literature

Background from the literature

==== In vitro differentiation ==== Muscle cells that were cultured with the transcription factor PRDM16 were converted into brown fat cells (presumably classical-like), and brown fat cells without PRDM16 were converted into muscle cells. Brown fat preadipocytes can be derived from pluripotent stem cells. This type of cell is commercially available as "i-HBrPAd". They are described as positive for PRDM16, without much information on whether they were derived from Myf5+ cells.

Diphenhydramine, while traditionally known as an antagonist, acts primarily as an inverse agonist of the histamine H1 receptor. It is a member of the ethanolamine class of antihistaminergic agents. By reversing the effects of histamine on the capillaries, it can reduce the intensity of allergic symptoms. It also crosses the blood–brain barrier and inversely agonizes the H1 receptors centrally. Its effects on central H1 receptors cause drowsiness. Diphenhydramine is a potent antimuscarinic (a competitive antagonist of muscarinic acetylcholine receptors) and, as such, at high doses can cause anticholinergic syndrome. The utility of diphenhydramine as an antiparkinson agent is the result of its blocking properties on the muscarinic acetylcholine receptors in the brain. Diphenhydramine also acts as an intracellular sodium channel blocker, which is responsible for its actions as a local anesthetic. Diphenhydramine has also been shown to inhibit the reuptake of serotonin. It has been shown to be a potentiator of analgesia induced by morphine, but not by endogenous opioids, in rats. The drug has also been found to act as an inhibitor of histamine N-methyltransferase (HNMT).

Leptin increases the production of leukocytes via actions on the hematopoietic niche, a pathway that is more active in sedentary mice and humans when compared to individuals who are physically active.

Sources: en.wikipedia.org

Related pages on this site

Further detail

EAR US Estimated Average Requirements. RDA US Recommended Dietary Allowances; higher for adults than for children, and may be even higher for women who are pregnant or lactating. AI US and EFSA Adequate Intake; AIs established when there is not sufficient information to set EARs and RDAs. PRI Population Reference Intake is European Union equivalent of RDA; higher for adults than for children, and may be even higher for women who are pregnant or lactating. For Thiamin and Niacin the PRIs are expressed as amounts per MJ of calories consumed. MJ = megajoule = 239 food calories. UL or Upper Limit Tolerable upper intake levels. ND ULs have not been determined. NE EARs have not been established.

=== Other nitrogen compounds === Chloroplasts make all of a cell's purines and pyrimidines—the nitrogenous bases found in DNA and RNA. They also convert nitrite (NO2−) into ammonia (NH3) which supplies the plant with nitrogen to make its amino acids and nucleotides.

== History == Rugby league started in Australia in the period 1907–08. The Australian Rugby Football League Board of Control was formed by the New South Wales Rugby League (NSWRL) and Queensland Rugby League (QRL) in December 1924 to administer the running of the national team. George Ball was the first secretary of the Board and John La Maro the first chairman. Prior to this time, the international rugby league was organised jointly by the NSWRL and the QRL. It was only after this time that the Australian team began to wear the now-familiar sporting colours of Green and Gold. Since 1924, rugby league bodies in all other states and territories became affiliated to the Board of Control and ARL. Until 1984 the ARFL Board of Control was effectively run by the NSWRL board, and many Queensland players and administrators throughout this period believed that the NSWRL used this power to the detriment of Queenslanders, especially with respect to national team selection. In 1986 the ARL was incorporated under the name Australian Rugby Football League Limited as a separate entity and Ken Arthurson was the first executive chairman of the new body. With national expansion of the competition implemented for the 1995 season the NSWRL passed control of the Winfield Cup competition to the ARL. Following Kerry Packer's announcement that his Optus Vision company owned both free-to-air and pay television broadcasting rights for the sport in Australia, News Corporation, controlled by Rupert Murdoch, undertook a bold bid to create a rival competition, Super League (Australia).

It scoffs at her for removing James' bracelet and reaches out to destroy Jesse's coffin when Lucie reveals herself and helps Grace fight. Jesse kills the demon, saving them. Lucie and Thomas Lightwood retrieve the plant to finish the antidote for the poison Christopher had developed. Thomas and Alastair create the elixir and go to the Silent City to distribute it, which is a huge success. After fleeing the city, James realizes that the person behind the attacks had to be his demonic grandfather. He enters the shadow realm to confront and stop Belial once and for all. After some time, Cordelia uses Cortana to cut through the Portal to help him. Belial reveals that the Mandikhor demon was raised partially in the physical world and partially in his realm, making it immune to sunlight. They battle the Mandikhor, but are gravely outmatched until James used his connection to Belial's realm to summon a tornado and kill it. Belial then approaches James to proposition him once again, to which Cordelia ran him through with Cortana. With Belial being severely wounded, the realm collapses, and James and Cordelia return to their own realm. Having been poisoned and depleted his strength when reaching into the realm, James is dying when they returned. Matthew tries healing runes, but they are not strong enough to save him. Unbeknownst to him, the ghost of Jesse Blackthorn gave James his last breath — which had been preserved in his locket to one day resurrect himself — saving his life. Days later, while still recovering from his ordeal, James is visited by Grace.

Sources: en.wikipedia.org

Supporting material

All ordinary matter is made up of combinations of chemical elements, each with its own atomic number, indicating the number of protons in the atomic nucleus. Additionally, elements may exist in different isotopes, with each isotope of an element differing in the number of neutrons in the nucleus. A particular isotope of a particular element is called a nuclide. Some nuclides are inherently unstable. That is, at some point in time, an atom of such a nuclide will undergo radioactive decay and spontaneously transform into a different nuclide. This transformation may be accomplished in a number of different ways, including alpha decay (emission of alpha particles) and beta decay (electron emission, positron emission, or electron capture). Another possibility is spontaneous fission into two or more nuclides. While the moment in time at which a particular nucleus decays is unpredictable, a collection of atoms of a radioactive nuclide decays exponentially at a rate described by a parameter known as the half-life, usually given in units of years when discussing dating techniques. After one half-life has elapsed, one half of the atoms of the nuclide in question will have decayed into a "daughter" nuclide or decay product. In many cases, the daughter nuclide itself is radioactive, resulting in a decay chain, eventually ending with the formation of a stable (nonradioactive) daughter nuclide; each step in such a chain is characterized by a distinct half-life.

=== Olfactory transfer === There is about 20 mL capacity in the adult human nasal cavity. The major part of the approximately 150 cm2 surface in the human nasal cavity is covered by respiratory epithelium, across which systemic drug absorption can be achieved. The olfactory epithelium is situated in the upper posterior part and covers approximately 10 cm2 of the human nasal cavity. The nerve cells of the olfactory epithelium project into the olfactory bulb of the brain, which provides a direct connection between the brain and the external environment. The transfer of drugs to the brain from the blood circulation is normally hindered by the blood–brain barrier (BBB), which is virtually impermeable to passive diffusion of all but small, lipophilic substances. However, if drug substances can be transferred along the olfactory nerve cells, they can bypass the BBB and enter the brain directly. The olfactory transfer of drugs into the brain is thought to occur by either slow transport inside the olfactory nerve cells to the olfactory bulb or by faster transfer along the perineural space surrounding the olfactory nerve cells into the cerebrospinal fluid surrounding the olfactory bulbs and the brain. Olfactory transfer could theoretically be used to deliver drugs that have a required effect in the central nervous system such as those for Parkinson's or Alzheimer's diseases. Studies have been presented showing that direct transfer of drugs is achievable.

On November 19, 2019, a lawsuit was filed by a vegan from Atlanta, Georgia, against Burger King for allegedly failing to clearly disclose that Impossible Whopper burgers were heated on the same grill as their beef burgers. The lawsuit was dismissed. On March 28, 2022, a lawsuit was filed against Burger King, alleging the fast food chain falsely advertised the Whopper to "look about 35% bigger in its advertising than it is in reality". On May 5, 2025, Federal Judge Roy Altman allowed the case to proceed, stating the claims may reasonably suggest consumers were misled and that Florida law permits such misrepresentation suits without a special relationship. Burger King argued that differences between ads and actual burgers are typical of handmade food and standard marketing practices.

=== Mousiness and geranium taint === Wines infected with L. brevis, L. hilgardii, and L. fermentum have been known to occasionally develop an aroma reminiscent of rodent droppings. The aroma becomes more pronounced when the wine is rubbed between the fingers and, if consumed, can leave a long, unpleasant finish. The aroma can be very potent, detectable at a sensory threshold as low as 1.6 parts per billion (μg/l). The exact compound behind this is derivatives of the amino acid lysine created through an oxidation reaction with ethanol. While undesirable LAB species have been most commonly associated with this fault, wine infected by Brettanomyces yeast in the presence of ammonium phosphate and lysine have also been known to exhibit this fault. Sorbate is often used as a yeast-inhibitor by home winemakers to stop alcoholic fermentation in the production of sweet wines. Most species of lactic acid bacteria can synthesize sorbate to produce 2-ethoxyhexa-3,5-diene which has the aroma of crushed geranium leaves.

Historically, many of the prestigious universities in Peru have been public, including the National University of San Marcos. Founded in May 1551, it is the top university in Peru and the oldest university in the Americas. To be admitted into one of the national public universities, students must have a high score on the admission test. In 2002, the most prestigious public universities joined and created the Strategic Alliance of Peruvian Universities, including National University of San Marcos, La Molina – National Agrarian University, National University of Engineering, Federico Villarreal University, and the National University of Callao. Other public and private universities joined as an associate or advisory members.

Sources: en.wikipedia.org

Frequently asked questions

Is AOD-9604 the same as human growth hormone?

No. It is a synthetic peptide fragment modeled on part of human growth hormone, not the full hormone. It does not contain the complete sequence or receptor-binding regions of hGH.

Was AOD-9604 approved for weight loss?

It was investigated in clinical trials for obesity, but it did not receive approval for that use in major markets. Results were generally modest or mixed, and it remains an experimental compound.

Why is AOD-9604 banned in sports?

WADA lists it as a prohibited peptide hormone. Its use can be detected by laboratory methods, and athletes are subject to sanctions if it is found in samples.

What is AOD-9604?

AOD-9604 is a synthetic peptide fragment of human growth hormone, corresponding to amino acids 176-191. It is studied for potential effects on fat metabolism, but it is not approved as a drug in most countries. Its exact mechanism remains under investigation.

Network